Further, it is shown that the inactivation of the known ABR target Rac1 in leukemia increases chemotherapy-induced apoptosis [37, 56], supporting a possible mechanism of ABR action in AML therapy via inhibition of Rac1. The gene discussed is RAC1; the disease is acute myeloid leukemia.